New Body Pro Scale and Blood Pressure Monitor are Connected by Sequans’ Monarch 2 GM02S
By every measure, the connected healthcare market is poised for significant growth in the coming years with a compound annual growth rate projected at 25.4 percent. Even though there exist concerns regarding data privacy and security, the ongoing advances in technology continue to outweigh these concerns and the market is growing steadily. Recent market research projects that the US connected healthcare market will grow from $28 billion to $182 billion between 2022 and 2030.
Cellular connectivity adds tremendous value to healthcare devices, and no one knows this better than Withings, a pioneer of the connected health movement, who is today using cellular to connect many of its newest and most advanced health devices. As compared to short-range connectivity such as Wi-Fi and Bluetooth, cellular enables always on connectivity and mobility, thereby enabling more advanced features and improved quality of life for users. Cellular connectivity also provides high-level security with end-to-end encryption, critically important for patient privacy and the security of data.
Withings builds a wide range of innovative healthcare devices, including activity trackers, connected scales, blood pressure monitors and advanced sleep analyzers. These devices collect data and provide users with vast amounts of useful information that can help them not only track key aspects of their healthcare, but also take ownership of it—a key growth driver.
Withings has partnered with Sequans, a leader in cellular IoT chips and modules, and is using Sequans Monarch 2 LTE-M/NB-IoT technology to connect its new generation of health devices. Two of the latest Sequans-powered products available from Withings today are the Body Pro smart scale and the BPM Connect Pro blood pressure monitor.
“We selected Sequans for our next generation of connected health solutions because we believe that Sequans’ Monarch 2 technology is reliable and delivers the lowest power consumption available today.”
—Withings
Withings Smart Scales
Body Pro is connected right out of the box because it uses the cellular network and does not have to be setup on a Wi-Fi network. Data is collected with every use with best-in-class accuracy. It measures weight and body mass index and keeps track of weight trends so that users are motivated to reach their goals and are reminded to do so. Body Pro is smart enough to automatically calibrate for geographic location and gravity compensation.
Body Pro 2 goes further and enables healthcare providers to go beyond weight by measuring body composition and may allow doctors to detect early signs of diabetic peripheral neuropathy and help in the assessment of diabetic foot ulcers 1, 2, 3. Body Pro 2 is also designed to boost consistent engagement by sending messages, reminders, and health nudges to users, keeping them continually engaged in their healthcare programs.
Withings BPM Connect Pro
BPM Connect Pro is connected by cellular and therefore provides medically accurate blood pressure readings from anyone, anywhere, even from those that don’t have Wi-Fi access. BPM Pro provides both immediate and full history readings and is very easy to use. Healthcare providers can improve the health of their patients through the accurate collection of blood pressure data that can be transferred instantly, securely, and seamlessly to the cloud and then accessed through any chosen interface.
Withings Body Pro and BPM Connect Pro are connected by Sequans’ Monarch 2 GM02S module—one of the most advanced and reliable LTE-M/NB-IoT connectivity solutions in the industry today. Monarch 2 GM02S is the world’s only cellular IoT module with an EAL5+ certified secure enclave for integrated eSIM that is compliant with GSMA standards. The module also features industry-leading low power consumption and global deployment capability. Please visit Sequans’ Monarch 2 GM02S web page.
1. David J. Margolis et al., « Economic Burden of Diabetic Foot Ulcers and Amputations: Data Points #3 », in Data Points Publication Series (Rockville (MD): Agency for Healthcare Research and Quality (US), 2011), http://www.ncbi.nlm.nih.gov/books/NBK65152
2. Bordier, Lyse, Manuel Dolz, Linsay Monteiro, Marie-Laure Névoret, Jean-Henri Calvet, et Bernard Bauduceau. « Accuracy of a Rapid and Non-Invasive Method for the Assessment of Small Fiber Neuropathy Based on Measurement of Electrochemical Skin Conductances ». Frontiers in Endocrinology 7 (29 février 2016): 18. https://doi.org/10.3389/fendo.2016.00018
3. J. H. Calvet et al., « Assessment of Small Fiber Neuropathy through a Quick, Simple and Non Invasive Method in a German Diabetes Outpatient Clinic », Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association 121, no 2 (février 2013): 80‑83, https://doi.org/10.1055/s-0032-1323777
